Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. - Wikidata - wikimedia - TriplyDB

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

http://www.wikidata.org/entity/Q36614480

about

A review on hepatocyte nuclear factor-1beta and tumor Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases Epigenetic determinants of ovarian clear cell carcinoma biology.Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.Genetic Variants in MMP9 and TCF2 Contribute to Susceptibility to Lung Cancer Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.RNA processing and mRNA surveillance in monogenic diabetes.A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.MicroRNA profiling differentiates colorectal cancer according to KRAS status.Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer

P2860

Q26783312-BD002688-79B7-48E2-AEDA-099701DBCD9B Q34011902-27A32EE8-B91C-4B74-B85B-B1178159C99F Q34523383-83017E51-118E-432E-92F3-7B659BEE0509 Q34658626-486155F2-DFF7-41C8-8827-8A660BCF1633 Q34990141-6CDD7540-9228-4AA3-88B4-A93DD17D98A8 Q35063160-5BD92EDC-AD66-4D45-B61E-D4C42E9E99ED Q35596108-CFEA35A2-867A-4A8D-AC91-566488DBFA62 Q35908353-EAAC15B0-971D-40F4-93D4-964A4FBB445C Q36094107-7533B619-EE85-44E5-A91F-165096BCDEE4 Q36654732-BB472469-35AB-4394-9329-A314BC42E06D Q36982136-F5ACC74A-CE4F-4528-B850-244EF9798AC7 Q37170593-B16B27FF-F3FE-46AD-A28D-D0E677C3DB55 Q37321839-0E97ABDB-5067-43F1-A50B-FD490D13B18F Q37644812-78EA7E0B-C032-4C7E-8F55-CDE9AE347448 Q37688836-D5A1F366-5324-43EB-B24D-810C2131345E Q37691118-3B6C3686-24EA-4DAC-813F-23FCC1D0E633 Q38868955-EF80D074-FCF6-46A5-B1A7-4123FC196E25 Q39628888-0BC6D2C1-CD26-4C96-8CD0-76FD3E8A8E2D Q40176040-89253026-D210-4D52-8F34-33C442AC9705 Q54348636-B8692A38-E898-470E-A836-AC84F5A63BED Q57847297-EC990569-AE5E-4996-9B0D-4EAEA626349F

P2860

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

http://www.wikidata.org/entity/Q36614480

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@ast

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@en

type

label

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@ast

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@en

prefLabel

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@ast

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@en

P1433

Q36614480-441224F8-4AB2-47C9-A695-D9BD69BAE89F

P1476

Q36614480-736DD66C-924C-4F60-A948-2447C3BBE43D

P2093

Q36614480-0042B616-8FB3-4C68-A0B8-9D24B12E9E49

Q36614480-35B8B5A0-B9C2-4B99-821F-7BB8C315A342

Q36614480-41280124-796F-42F8-ACDB-90D96D99F6BD

Q36614480-4EB2C4EE-0CBC-45B1-A979-6C4C51B4C586

Q36614480-614F0AA0-0EDA-46B8-B21F-E13D2C6FCB49

Q36614480-643B2235-3E44-45D7-A3BB-396107E7F3C6

Q36614480-9FB0BE67-ACFB-4CF3-9A53-5AB7B7E9277B

Q36614480-A935F4CD-06C1-4DEE-8E56-D0255F8B02D4

Q36614480-AF153B61-AD97-436C-B3FE-79FF022386A5

Q36614480-B45C001A-BBBD-4EC4-8655-CE6E61B1C9BB

P2860

Q36614480-01016288-AF21-4205-983B-5D7EA2462CCC

Q36614480-043B2992-E2A5-44ED-B4C7-6A14C1208F27

Q36614480-09BB7590-B230-4444-96D0-A9E0E41D2838

Q36614480-1061240A-0C54-41E6-96E0-6C8A30A17A74

Q36614480-11A1F8D1-6332-4F48-AA07-B3F1575A51EF

Q36614480-122631BB-413D-4CF9-8D75-945A1BB28EC4

Q36614480-1C4E4922-8FFA-4918-9236-A2898716D367

Q36614480-1CFEDA32-32B2-4FE7-B259-DB64303113DE

Q36614480-1E57E730-95A9-4C1F-B31E-F7161C9F8844

Q36614480-387ED145-632D-45D3-B184-0E43CE9166F7

P2888

Q36614480-48123247-B49B-41A2-BC97-2A43CC2F83EF

P304

Q36614480-965B7F80-F8FC-40EC-980F-2C4B23572241

P31

Q36614480-14BD7F0B-855B-43EC-ACEE-EC93FA647904

P356

Q36614480-885CD5CB-2A1C-48BC-9241-85F38654B0B4

P407

Q36614480-EBE92AA4-8716-4241-BA5C-CC33EBD4DEA9

P433

Q36614480-17261E69-A113-4949-917E-4317E06C2E17

P478

Q36614480-E3CA5C58-1C32-4EA3-9A36-9327ABFC0595

P577

Q36614480-2B3E3DAA-BD20-4D17-AFE3-5AF253742621

P5875

Q36614480-E3B2DA62-992B-4E9B-A7DB-392352EEEC0D

P698

Q36614480-F54B699D-027B-471E-BF32-1D2A6A2FD04C

P921

Q36614480-4AD8E0D1-FD97-42F6-9FAD-737C7DF493B9

P932

Q36614480-B79C5CA9-CCB5-4E07-A518-B3BB6A6686E9

P356

P1433

British Journal of Cancer

P1476

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

@en

P2093

H Suzuki

http://www.w3.org/2001/XMLSchema#string

K Akino

http://www.w3.org/2001/XMLSchema#string

K Imai

http://www.w3.org/2001/XMLSchema#string

K Ogi

http://www.w3.org/2001/XMLSchema#string

K Terasawa

http://www.w3.org/2001/XMLSchema#string

M Toyota

http://www.w3.org/2001/XMLSchema#string

N Nishikawa

http://www.w3.org/2001/XMLSchema#string

R Maruyama

http://www.w3.org/2001/XMLSchema#string

S Sagae

http://www.w3.org/2001/XMLSchema#string

T Saito

http://www.w3.org/2001/XMLSchema#string

P2860

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

High sensitivity mapping of methylated cytosines

GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer

The fundamental role of epigenetic events in cancer

The power and the promise of DNA methylation markers

Bi-allelic inactivation of TCF1 in hepatic adenomas

Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters

vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1

Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis.

Lack of TCF2/vHNF1 in mice leads to pancreas agenesis

P2888

P304

914-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602984

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232774159

http://www.w3.org/2001/XMLSchema#string

P698

16479257

http://www.w3.org/2001/XMLSchema#string

P921

P932

2361363

http://www.w3.org/2001/XMLSchema#string